-
Its estimated that 859 out of 100,000 women of reproductive age receive a cancer diagnosis each year in the United States. Up to 80% of all women diagnosed with cancer prior to age 50 survive at least five years.
-
Results from the 2013 National Youth Risk Behavior Survey indicate that among high school students who are sexually active, condom use has declined from 63% in 2003 to 59% in 2013. This decline follows a period of increased condom use throughout the 1990s and early 2000s.
-
New chlamydia prevalence estimates confirm that young women particularly young African American women continue to bear a disproportionate burden of disease in the United States.
-
Bayer HealthCare Pharmaceuticals has received Food and Drug Administration approval for a new inserter for its Mirena intrauterine contraceptive.
-
Respiratory illnesses are a common cause for a visit to the pediatric emergency department (ED). A good number of the patients who present for respiratory infections will have illnesses such as upper respiratory infections (i.e., common colds) and bronchiolitis.
-
Daily intake of a single strain probiotic supplement (Bl-04) was associated with a decreased risk of UTRIs in healthy adults.
-
Two recent studies have found that concomitant use of prescription medications and dietary supplements is common.
-
Osteopathic manipulative therapy (OMT) during the third trimester appears to help prevent the progression of back pain and the loss of back functioning with time.
-
A second inhalation rapid human insulin has been approved by the FDA. The first inhaled insulin (Exubera) was approved in 2006 and was withdrawn from the market by Pfizer due to low acceptance and poor sales after about 13 months on the market
-
In a meta-analysis of multiple prospective cohort studies, the lowest vitamin D metabolite (25-hydroxyvitamin D) quintile was associated with increased all-cause mortality, cardiovascular mortality, and cancer mortality.